Comparison of the Effect of A-PRF and L-PRF on Outcomes After Removal of Impacted Mandibular Third Molar
Comparison of the Effect of Advanced Platelet-rich Fibrin and Leukocyte- and Platelet-rich Fibrin on Outcomes After Removal of Impacted Mandibular Third Molar: A Randomised Split-mouth Study
1 other identifier
interventional
27
1 country
1
Brief Summary
In this study, it was aimed to investigating and comparing the postoperative effects of leukocyte- and platelet-rich fibrin (L-PRF) and advanced platelet-rich fibrin (A-PRF) in terms of pain, swelling on the cheek, and trismus after mandibular third molar surgery. The study included a total of 27 patients with bilateral impacted mandibular third molar which surgically operated at different times. Patients were evaluated in two randomly separated groups. For the first group; A-PRF and for the second group; L-PRF was applied into the tooth socket. The outcomes variables were; pain, swelling, the number of analgesics taken, and trismus. These variables were also assessed on the basis of; 1st, 2nd, 3rd and 7th days following the operation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2017
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 5, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
May 20, 2018
CompletedFirst Submitted
Initial submission to the registry
September 11, 2018
CompletedFirst Posted
Study publicly available on registry
September 14, 2018
CompletedSeptember 14, 2018
September 1, 2018
4 months
September 11, 2018
September 13, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Pain Scores Evaluted
For the postoperative period, the pain scores change was evaluated with the help of the visual analog scale (VAS) ranging from 0 (no pain) to 10 (most severe pain).
1st day after the operation.
Pain Scores Evaluted
For the postoperative period, the pain scores change was evaluated with the help of the visual analog scale (VAS) ranging from 0 (no pain) to 10 (most severe pain).
2nd day after the operation.
Pain Scores Evaluted
For the postoperative period, the pain scores change was evaluated with the help of the visual analog scale (VAS) ranging from 0 (no pain) to 10 (most severe pain).
3rd day after the operation.
Pain Scores Evaluted
For the postoperative period, the pain scores change was evaluated with the help of the visual analog scale (VAS) ranging from 0 (no pain) to 10 (most severe pain).
7th day after the operation.
Secondary Outcomes (3)
Number of Analgesics Taken by the Patients
Each patient was evaluated on the 1st, 2nd, 3rd, and 7th days after the operation.
Trismus
Each patient was evaluated in order to obtain measurements on the 1st, 2nd, 3rd, and 7th days after the operation.
Swelling on the cheek
Each patient was evaluated in order to obtain measurements on the 1st, 2nd, 3rd, and 7th days after the operation.
Study Arms (2)
Advanced Platelet Rich Fibrin (A-PRF)
ACTIVE COMPARATORA-PRF was applied into the tooth socket after mandibular third molar surgery.
Leukocyte- and platelet-rich fibrin (L-PRF)
ACTIVE COMPARATORL-PRF was applied into the tooth socket after mandibular third molar surgery.
Interventions
blood samples collected in 10 ml of vacuumed plain glass tubes were centrifuged for 14 minutes at 1500 rpm without anticoagulant agents in order to obtain A-PRF
blood samples collected in 10 ml of glass coated plastic tubes were centrifuged without anticoagulant agents for 10 minutes in order to obtain L-PRF
Eligibility Criteria
You may qualify if:
- age≥18
- the presence of bilaterally symmetrically impacted mandibular third molar, which requires an extraction for prophylactic reasons
- absence of systemic diseases
- absence of chronic opioid taken;
- not being pregnant
- not smoking and no alcohol usage
- the absence of allergy to penicillin or any other drugs used during standardized postoperative therapy.
You may not qualify if:
- tooth needed to be sectioning during the operation
- operation time exceeding 30 minutes
- the cases with severe periodontal disease or acute pericoronitis,
- the cases using antibiotics for an existing infection
- the cases not capable of following postoperative instructions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Near East University
Mersin, 99138, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mehmet G Caymaz, DDS
Near East University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Assistant
Study Record Dates
First Submitted
September 11, 2018
First Posted
September 14, 2018
Study Start
November 5, 2017
Primary Completion
March 1, 2018
Study Completion
May 20, 2018
Last Updated
September 14, 2018
Record last verified: 2018-09